21 C.F.R. § 556.445

Nicarbazin.

Last amended: 2019Year: 2026Length: 54 wordsSubsections: 3Official source

Cite as 21 C.F.R. § 556.445 (2026)

(a) Acceptable daily intake (ADI). The ADI for total residues of nicarbazin (4,4′-dinitrocarbanilide and 2-hydroxy-4,6-dimethylpyrimidine) is 200 µg/kg of body weight per day. (b) Tolerances. The tolerance for 4,4′-dinitrocarbanilide (marker residue) is: (1) Chickens. Liver (target tissue): 52 ppm. (2) [Reserved] (c) Related conditions of use. See §§ 558.364 and 558.366 of this chapter.
Cross-references to the CFR
558.364
21 C.F.R. § 556.445: Nicarbazin. | Justis AI